[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-354027-105":59,"doc-detail-354027-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rbm3-associated-germline-variants-and-their-functional-role-in-gastric-cancer-susceptibility-and-progression","RBM3-associated germline variants and their functional role in gastric cancer susceptibility and progression","","Genome-wide association study integration with experimental validation was used to clarify the genetic contribution and functional role of RNA-binding motif protein 3 (RBM3) in gastric cancer. RBM3-associated expression quantitative trait loci were derived from 3,301 individuals and tested for association with gastric cancer risk in a large-scale GWAS of 456,348 individuals. Colocalization relied on stomach tissue eQTL data, with RBM3 expression measured in 60 paired tumor and adjacent tissues and multiple cancer cell lines. Functional assays assessed proliferation, colony formation, migration, invasion, and xenograft tumor growth, demonstrating RBM3’s tumor-suppressive effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rbm3-associated-germline-variants-and-their-functional-role-in-gastric-cancer-susceptibility-and-progression/354027/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rbm3-associated-germline-variants-and-their-functional-role-in-gastric-cancer-susceptibility-and-progression/354027.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were RBM3-associated variants linked to gastric cancer risk?","Question",{"text":112,"@type":113},"RBM3-associated expression quantitative trait loci were identified from a GWAS of 3,301 individuals and evaluated against gastric cancer risk using a large-scale GWAS comprising 456,348 individuals. Colocalization analysis used stomach tissue eQTL data to support shared signals.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What did the study find about RBM3 expression in gastric cancer tissues?",{"text":117,"@type":113},"RBM3 expression was significantly reduced in gastric cancer tissues compared with adjacent normal tissues. Low RBM3 expression correlated with advanced tumor stage, lymph node and distant metastasis, and larger tumor size.",{"name":119,"@type":110,"acceptedAnswer":120},"What functional evidence supports RBM3 as a tumor suppressor in gastric cancer?",{"text":121,"@type":113},"RBM3 overexpression inhibited proliferation, clonogenicity, migration, and invasion in vitro. In vivo, RBM3 overexpression suppressed xenograft tumor growth, reduced Ki67-positive proliferation, and enhanced apoptotic activity.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},354027,1790489179,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","TYPE Original Research PUBLISHED 01 April 2026  \nDOI 10.3389/fonc.2026.1790197  \nOPEN ACCESS  \nEDITED BY  \nKanjoormana Aryan Manu,  \nAmala Cancer Research Centre, India  \nREVIEWED BY  \nJiaqiang Huang,  \nBeijing Jiaotong University, China Vishnu Priya Murali,  \nAmala Institute of Medical Sciences, India  \n*CORRESPONDENCE  \nXueying Wu  \n[wuxueying126@126.com](wuxueying126@126.com)  \nRECEIVED 17 January 2026  \nREVISED 12 March 2026  \nACCEPTED 18 March 2026  \nPUBLISHED 01 April 2026  \nCITATION  \nZheng Q, Peng S and Wu X (2026) RBM3-associated germline variants and their functional role in gastric cancer susceptibility and progression.  \nFront. Oncol. 16:1790197 .  \ndoi: 10.3389/fonc.2026.1790197  \nCOPYRIGHT  \n© 2026 Zheng, Peng and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRBM3-associated germline variants and their functional role in gastric cancer susceptibility and progression  \nQingsheng Zheng, Shuai Peng and Xueying Wu*  \nDepartment of General surgery, The Afﬁliated People’s Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China  \nBackground: Gastric cancer (GC) is the ﬁfth most commonly diagnosed malignancy and the fourth leading cause of cancer-related mortality worldwide. RNA-binding motif protein 3 (RBM3) has been associated as a prognostic marker in several cancers; however, its genetic contribution and functional role in gastric cancer remain unclear.  \nMethods: Genome-wide association study (GWAS) data was integrated with experimental validation to investigate the role of RBM3 in GC. RBM3-associated expression quantitative trait loci (eQTLs) were identiﬁed from a GWAS of 3,301 individuals and evaluated for their association with GC risk using a large-scale GWAS comprising 456,348 individuals. Colocalization analysis was performed using stomach tissue eQTL data. RBM3 expression was assessed in 60 paired GC and adjacent normal tissues and in multiple GC cell lines. Functional effects of RBM3 modulation were examined through proliferation, colony formation, migration, invasion, and xenograft assays.  \nResults: Several independent variants within the RBM3 locus showed a consistent protective association with GC risk and were linked to RBM3 expression regulation. RBM3 expression was signiﬁcantly reduced in GC tissues compared with adjacent normal tissues (P \u003C 0 . 001) . Low RBM3 expression correlated with advanced tumor stage (III–IV), lymph node and distant metastasis, and larger tumor size. Functionally, RBM3 overexpression inhibited GC cell proliferation, clonogenicity, migration, and invasion in vitro. In vivo, RBM3 overexpression suppressed xenograft tumor growth, reduced Ki67-positive proliferation, and enhanced apoptotic activity.  \nConclusion: Our ﬁndings demonstrate that RBM3 acts as a genetically supported tumor suppressor in gastric cancer . RBM3-associated germline variants contribute to GC susceptibility, and RBM3 downregulation promotes aggressive tumor behavior. RBM3 therefore represents a promising biomarker and potential therapeutic target in gastric cancer.  \nKEYWORDS  \napoptosis, bioinformatics analysis, gastric cancer, public databaseresearch, RBM3, single nucleotide polymorphism  \nFrontiers in Oncology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nGastric cancer (GC) is ranked as ﬁfth most commonly diagnosed malignancy and thus remains as major global health burden. It is the fourth top cause of cancer-related death throughout the globe (1). In 2020 alone, GC was responsible for approximately 1.09 million new cases and 0.77 million deaths (2) . In spite of ","cbCaisNGDwqDXxhS","https://ap.wps.com/l/cbCaisNGDwqDXxhS","pdf",4968139,13,"English","# Introduction\n# Methods\n# Results\n# Conclusion","[{\"question\":\"How were RBM3-associated variants linked to gastric cancer risk?\",\"answer\":\"RBM3-associated expression quantitative trait loci were identified from a GWAS of 3,301 individuals and evaluated against gastric cancer risk using a large-scale GWAS comprising 456,348 individuals. Colocalization analysis used stomach tissue eQTL data to support shared signals.\"},{\"question\":\"What did the study find about RBM3 expression in gastric cancer tissues?\",\"answer\":\"RBM3 expression was significantly reduced in gastric cancer tissues compared with adjacent normal tissues. Low RBM3 expression correlated with advanced tumor stage, lymph node and distant metastasis, and larger tumor size.\"},{\"question\":\"What functional evidence supports RBM3 as a tumor suppressor in gastric cancer?\",\"answer\":\"RBM3 overexpression inhibited proliferation, clonogenicity, migration, and invasion in vitro. In vivo, RBM3 overexpression suppressed xenograft tumor growth, reduced Ki67-positive proliferation, and enhanced apoptotic activity.\"}]","RBM3-associated germline variants and their functional role in gastric cancer susceptibility and progression | PDF",1790108508,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9ef1e954b508c19be0b259d4c6434b78.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/26845759fe722fb6469dc8e324d57e25.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c25aa879a474f2db43d84aaf1b8dec42.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48ec87242621e72f396310e2807b35ff.webp",980,1385]